Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus is a research paper published in American Heart Journal (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Agence Nationale de la Recherche
Grant: ANR-15-RHUS-0004
Canadian Cardiovascular Society
Alberta Innovates - Health Solutions
National Institutes of Health
European Society of Cardiology
Bayer Canada
Boehringer Ingelheim
Johnson and Johnson
Novartis
AstraZeneca Canada
National Institute on Aging
Servier
Boston Scientific Corporation
Roche
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial
Additional file 1 of Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial